BioMarin’s Voxzogo (vosoritide) won FDA approval in paediatric achondroplasia in November 2021 and secured a label extension ...
The anti-parasitic drug became a household name during the COVID-19 pandemic, and it is now being embraced as an alternative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results